Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
Systemic Therapy for Melanoma: ASCO Guideline Rapid Recommendation UpdateRahul Seth, Hans Messersmith, Pauline Funchain, et al.Breast Cancer Research and Treatment|May 29, 2007
Gemcitabine in the management of metastatic breast cancer: a systematic reviewSusan Dent, Hans Messersmith, Maureen TrudeauJournal of Clinical Epidemiology|September 14, 2014
Priority-based initiative for updating existing evidence-based clinical practice guidelines: the results of two iterationsChika Agbassi, Hans Messersmith, Sheila McNair, et al.Cancer Treatment Reviews|January 1, 2008
Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic reviewAndrea Eisen, Maureen Trudeau, Wendy Shelley, et al.Annals of Internal Medicine|May 7, 2008
Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancerEllen Warner, Hans Messersmith, Petrina Causer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2025
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation UpdateJaishri Blakeley, Nimish A Mohile, Hans Messersmith, et al.Cancer Treatment Reviews|May 27, 2008
Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: a systematic reviewYolanda Madarnas, Maureen Trudeau, Jacob A Franek, et al.Breast Cancer Research and Treatment|July 20, 2007
HER2/neu in systemic therapy for women with breast cancer: a systematic reviewBindi Dhesy-Thind, Kathleen I Pritchard, Hans Messersmith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2008
HER-2 and topoisomerase II as predictors of response to chemotherapyKathleen I Pritchard, Hans Messersmith, Leela Elavathil, et al.JCO Oncology Practice|December 1, 2023
Systemic Therapy for Melanoma: ASCO Guideline Update Q and AVernon K Sondak, Michael B Atkins, Hans Messersmith, et al.Pageof 3